CJC-1295 With DAC (5mg)

Description

Product: CJC-1295 With DAC (5mg) Product Overview: CJC-1295 With DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), designed to mimic aspects of the natural signaling sequence associated with growth hormone secretion. Composed of 30 amino acids, it is modified with a Drug Affinity Complex (DAC) to enhance its biochemical stability and extend its half-life. This modification has made CJC-1295 With DAC a subject of interest in research investigating prolonged peptide activity and receptor interactions in preclinical models. Research Profile: CJC-1295 With DAC has been studied in laboratory models for its potential effects on endocrine signaling and peptide stability. Its modification with DAC has been investigated for its ability to sustain interaction with GHRH receptor pathways, potentially allowing extended research timelines. - Endocrine System Studies: Investigated for its potential to influence growth hormone secretion through GHRH receptor pathways in preclinical research. - Peptide Stability: Studied for its extended half-life, which may enhance receptor binding and reduce degradation under experimental conditions. - Cellular Signal Transduction: Evaluated for its potential effects on cyclic AMP (cAMP) pathways, which are key signaling mechanisms within endocrine cells. - Protein Synthesis: Examined in laboratory models for its role in initiating downstream processes associated with growth hormone activity. - Biochemical Receptor Interactions: Research focuses on its affinity and selectivity for GHRH receptors, comparing its binding characteristics to unmodified peptides. Key Research Applications: CJC-1295 With DAC is frequently studied in laboratory models to explore its extended peptide activity and receptor interactions. - Growth Hormone Pathway Investigation: Utilized in research exploring the mechanisms of growth hormone release and associated cellular processes in preclinical models. - Endocrine Response Studies: Evaluated in models examining the broader effects of GHRH analogs on endocrine system function. - Peptide Stability Research: Investigated for its DAC modification, which enhances stability and prolongs peptide activity under controlled experimental conditions. - Signal Transduction Dynamics: Studied in laboratory settings for its potential influence on intracellular signaling cascades, particularly those involving cAMP. Specifications: Peptide Content: 5 mg per vial Appearance: Lyophilized powder Storage & Handling: Store in a cool, dry environment protected from light and moisture. Reconstitution and handling should be performed using standard laboratory procedures and appropriate laboratory controls.